Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias?

Samy Suissa

Source: Eur Respir J, 53 (2) 1802112; 10.1183/13993003.02112-2018

Journal Issue: February

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Samy Suissa. Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias?. Eur Respir J, 53 (2) 1802112; 10.1183/13993003.02112-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Inhaled steroids and mortality in COPD: bias from unaccounted immortal time Source: Eur Respir J 2004; 24: 190-191 Year: 2004
Inhaled beta2-agonists and death for asthma: can we overcome this risk? Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths Year: 2007
Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009
Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901035; 10.1183/13993003.01035-2019 Year: 2019
Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901276; 10.1183/13993003.01276-2019 Year: 2019
Inhaled therapy reduces COPD mortality Source: ERJ Open Res, 6 (4) 00634-2020; 10.1183/23120541.00634-2020 Year: 2020
Does inhaled corticosteroid use affect the risk of ?COVID-19-related death? Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020 Year: 2021
Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020
Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016
Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics Source: Eur Respir J 2001; 17: 380-385 Year: 2001
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia Source: Eur Respir J 2010; 36: 751-757 Year: 2010
Low-dose corticosteroids during severe community-acquired pneumonia: end of the story Source: Eur Respir J 2015; 45: 305-307 Year: 2015
Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016
Asthma progression and mortality: the role of inhaled corticosteroids Source: Eur Respir J, 54 (1) 1900491; 10.1183/13993003.00491-2019 Year: 2019
Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? Source: Eur Respir J 2011; 37: 1-3 Year: 2011
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012
Inhaled drugs as risk factors for community-acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Inhaled steroids as an intervention on long-term outcome of cough variant asthma Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001
Inhaled corticosteroids in COPD: the case against Source: Eur Respir J 2009; 34: 13-16 Year: 2009